Show simple item record

FieldValueLanguage
dc.contributor.authorCaskey, Fergus J.
dc.contributor.authorMorton, Rachael L.
dc.date.accessioned2023-02-15T01:58:31Z
dc.date.available2023-02-15T01:58:31Z
dc.date.issued2017en_AU
dc.identifier.urihttps://hdl.handle.net/2123/30031
dc.description.abstractThe theme for World Kidney Day in 2016 was “kidney disease and children: act early to prevent it”. Given the adverse effect of renal replacement therapy—dialysis and transplantation—on quality of life and health care resources, few would disagree with this ambition. For some children, however, end-stage kidney disease cannot be avoided and its effects have to be managed and outcomes optimised. With increasing fiscal pressures on health services in many settings around the world, the Article in The Lancet by Nicholas Chesnaye and colleagues looking at macroeconomics and survival on renal replacement therapy in Europe is timely.en_AU
dc.publisherElsevieren_AU
dc.relation.ispartofThe Lanceten_AU
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivatives 4.0en_AU
dc.subjectOptimising Careen_AU
dc.subjectChildren with Kidney Diseaseen_AU
dc.titleOptimising care for children with kidney diseaseen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1016/S0140-6736(17)30267-2
usyd.facultySeS faculties schools::Faculty of Medicine and Health::NHMRC Clinical Trials Centreen_AU
workflow.metadata.onlyYesen_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.